TD Asset Management
IMCR icon

TD Asset Management’s Immunocore IMCR Stock Holding History

TD Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Sell
103,558
-32,270
-24% -$955K ﹤0.01% 888
2026
Q1 		$4.1M Sell
135,828
-156,936
-54% -$5.08M ﹤0.01% 827
2025
Q4 		$10.2M Buy
292,764
+3,904
+1% +$138K 0.01% 648
2025
Q3 		$10.5M Buy
288,860
+2,596
+0.9% +$88.2K 0.01% 646
2025
Q2 		$8.98M Sell
286,264
-9,590
-3% -$298K 0.01% 660
2025
Q1 		$8.78M Sell
295,854
-21,622
-7% -$649K 0.01% 667
2024
Q4 		$9.37M Buy
317,476
+4,524
+1% +$143K 0.01% 662
2024
Q3 		$9.83M Buy
312,952
+48,056
+18% +$1.75M 0.01% 647
2024
Q2 		$8.98M Buy
264,896
+49,882
+23% +$2.54M 0.01% 638
2024
Q1 		$14M Sell
215,014
-131,916
-38% -$9.05M 0.01% 564
2023
Q4 		$23.7M Buy
346,930
+45,010
+15% +$2.34M 0.02% 434
2023
Q3 		$15.7M Buy
301,920
+158,086
+110% +$9.36M 0.02% 488
2023
Q2 		$8.62M Buy
143,834
+47,581
+49% +$2.72M 0.01% 632
2023
Q1 		$4.76M Buy
96,253
+3,347
+4% +$188K 0.01% 762
2022
Q4 		$5.3M Buy
92,906
+12,500
+16% +$704K 0.01% 738
2022
Q3 		$3.69M Buy
80,406
+52,900
+192% +$2.52M ﹤0.01% 825
2022
Q2 		$1.03M Hold
27,506
– – ﹤0.01% 1179
2022
Q1 		$822K Hold
27,506
– – ﹤0.01% 1265
2021
Q4 		$942K Hold
27,506
– – ﹤0.01% 1290
2021
Q3 		$1.02M Hold
27,506
– – ﹤0.01% 1246
2021
Q2 		$900K Hold
27,506
– – ﹤0.01% 1284
2021
Q1 		$1.17M Buy
+27,506
New +$1.22M ﹤0.01% 1238

Other funds holding IMCR

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TD Asset Management's IMCR Position: Q2 2026 in Review

TD Asset Management reduced its Immunocore (IMCR) stake by 24% in Q2 2026, selling an estimated $955K and leaving 103,558 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #888.

TD Asset Management first reported a position in IMCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $23.7M in Q4 2023. 72 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • TD Asset Management held 103,558 shares of Immunocore worth $3.29M as of Q2 2026.
  • TD Asset Management sold 32,270 Immunocore shares in Q2 2026, an estimated $955K.
  • Immunocore made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #888 holding.
  • TD Asset Management first reported a position in Immunocore in Q1 2021 and has held it in 22 quarters since.
  • TD Asset Management's Immunocore position peaked at $23.7M in Q4 2023.
  • 72 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.